share_log

荣昌生物实际控制人控制的企业累计增持18万股公司股份 涉资510.9万元

The actual controller of Remegen has accumulated a shareholding of 0.18 million shares in the company, involving 5.109 million yuan.

新浪港股 ·  Jul 16 20:56

Remegen (09995) announced the progress of the enterprise's shareholding in the company controlled by the actual controller. From July 9, 2024 to July 16, 2024, the actual controllers of the company, Wang Weidong, Fang Jianmin, Lin Jian, Wang Liqiang, Wang Xudong, Deng Yong, Xiong Xiaobin, Yang Minhua, Wen Qingkai, and Wei Jianliang, through their controlled enterprise, Yantai Rongchang Holding Group Co., Ltd., accumulated an additional 0.18 million shares of the company's stock through the Shanghai Stock Exchange system in a centralized bidding manner, accounting for 0.0331% of the total share capital of the company. The total amount of the additional shareholding was RMB 5.109 million yuan (excluding transaction fees), which has exceeded 50% of the lower limit amount of RMB 10 million yuan in this additional shareholding plan. The plan has not yet been fully implemented. Yantai Rongchang Holding Group Co., Ltd. will continue to increase its shareholding in the company within the implementation period of the relevant shareholding plan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment